Breast Cancer Association Consortium (BCAC) United Kingdom (UK)
Research
Date range: 1 December 2022 - 30 November 2023
Research collaboration: Breast Cancer Association Consortium (BCAC) is a research collaboration whose article contributions are accrued to its participating partner institutions.
Relationships
Partner Institutions
Breast Cancer Association Consortium (BCAC) is a research collaboration whose article contributions are accrued to its participating partner institutions below.
- Cancer Council Victoria
- Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology (IKP)
- Genome Institute of Singapore (GIS), A*STAR
- German Cancer Research Center in the Helmholtz Association (DKFZ)
- Hannover Medical School (MHH)
- Helsinki University Central Hospital (HUCH)
- Karolinska Institute (KI)
- Kuopio University Hospital (KUH)
- London School of Hygiene and Tropical Medicine (LSHTM)
- Maria Sklodowska-Curie National Research Institute of Oncology
- Mayo Clinic
- NIH NCI at Frederick
- NIH National Cancer Institute (NCI)
- National Cancer Center (NCC)
- National Cancer Institute of Thailand (NCI)
- Netherlands Cancer Institute (NKI)
- Nofer Institute of Occupational Medicine (NIOM)
- QIMR Berghofer Medical Research Institute
- Seoul National University (SNU)
- Spanish National Cancer Research Centre (CNIO)
- The Institute of Cancer Research (ICR)
- The University of Melbourne (UniMelb)
- The University of Sheffield
- Ulm University
- University of Cambridge
- University of Copenhagen (UCPH)
- University of Eastern Finland (UEF)
- University of Minnesota (UMN)
- University of Otago
- University of Tübingen (Uni Tübingen)
- University of Ulsan (UOU)
- WHO International Agency for Research on Cancer (IARC)